These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 28095223)

  • 1. Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects.
    Casellas D; Herizi A; Artuso A; Mimran A; Jover B
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S84-S90. PubMed ID: 28095223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candesartan and progression of preglomerular lesions in N(G)-nitro-L-arginine methyl ester hypertensive rats.
    Casellas D; Benahmed S; Artuso A; Jover B
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S230-3. PubMed ID: 9892169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
    Nakamura Y; Ono H; Zhou X; Frohlich ED
    Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide and preglomerular vascular lesions in lyon spontaneously hypertensive rats.
    Casellas D; Bouriquet N; Artuso A
    Acta Physiol Scand; 2000 Jan; 168(1):133-8. PubMed ID: 10691791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.
    Azegami T; Sasamura H; Hayashi K; Itoh H
    Hypertens Res; 2012 May; 35(5):492-9. PubMed ID: 22158111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of cardiovascular remodelling with candesartan.
    Brown L; Fenning A; Shek A; Burstow D
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S141-S147. PubMed ID: 28095240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with ibuprofen and the AT1 receptor antagonist candesartan in young spontaneously hypertensive rats.
    Pollock DM; Morsing P
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S116-9. PubMed ID: 9892151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats.
    Hsieh NK; Wang JY; Liu JC; Wang SD; Chen HI
    Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):212-8. PubMed ID: 15053816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM; Robertson SJ; Burns KD; deBlois D
    Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide dismutase mimetic, tempol, aggravates renal injury in advanced-stage stroke-prone spontaneously hypertensive rats.
    Sugama I; Kohagura K; Yamazato M; Nakamura T; Shinzato T; Ohya Y
    J Hypertens; 2014 Mar; 32(3):534-41. PubMed ID: 24309490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
    Akashiba A; Ono H; Ono Y; Ishimitsu T; Matsuoka H
    J Cardiol; 2008 Dec; 52(3):239-46. PubMed ID: 19027602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
    Demeilliers B; Mimran A; Jover B
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S208-12. PubMed ID: 9892165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X; Matavelli LC; Ono H; Frohlich ED
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preglomerular sudanophilia in L-NAME hypertensive rats: involvement of endothelin.
    Bouriquet N; Dupont M; Herizi A; Mimran A; Casellas D
    Hypertension; 1996 Mar; 27(3 Pt 1):382-91. PubMed ID: 8698442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic Contribution to the Vasodilator Effect of Chronic AT(1) Receptor Blockade in SHR.
    Paull JR; Li XC; Sampey DB; Widdop RE
    Hypertension; 2001 Jan; 37(1):91-98. PubMed ID: 11208762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.